1. Home
  2. ATXG vs BBLG Comparison

ATXG vs BBLG Comparison

Compare ATXG & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

HOLD

Current Price

$0.32

Market Cap

3.1M

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.16

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATXG
BBLG
Founded
2014
2004
Country
China
United States
Employees
112
N/A
Industry
Professional Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATXG
BBLG
Price
$0.32
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
19.2K
Earning Date
02-13-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.57
52 Week High
$1.86
$5.98

Technical Indicators

Market Signals
Indicator
ATXG
BBLG
Relative Strength Index (RSI) 53.41 37.08
Support Level $0.27 $1.11
Resistance Level $0.49 $1.36
Average True Range (ATR) 0.06 0.07
MACD 0.01 0.01
Stochastic Oscillator 42.87 2.38

Price Performance

Historical Comparison
ATXG
BBLG

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: